Armored CD19-targeted CAR T cells

CD19-targeted CAR T cell therapy · Memorial Sloan Kettering Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Armored CD19-targeted CAR T cells, covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of "Armored" CAR T Cells Targeting CD19 For Patients With Relapsed CD19+ Hematologic Malignancies [Phase 1]

See pricing